Phase 3 Stomach Cancer Trial, Recruiting NCT07018661 Sponsor: Leiden University Medical Center Condition: Stomach Cancer
Back to Stomach Cancer

Phase 3 Stomach Cancer Trial, Recruiting

NCT07018661
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been confirmed through a stomach camera (gastroscopy) to have a type of stomach cancer called adenocarcinoma, located in the stomach or at the lower junction where the food pipe meets the stomach (a specific subtype called Siewert type III)
  • People aged 18 years or older
  • People whose cancer is considered operable (not yet spread to distant parts of the body) based on a stomach camera and a CT scan with contrast dye, and where a medical team has recommended stomach removal surgery as a treatment option
  • People who have signed a written consent form agreeing to take part in the trial
  • People who have recently taken part in another clinical trial involving an experimental medicine may still be considered, if the trial team determines there is unlikely to be any interference with this study's procedures (confirm with trial site)

Who may not be able to join:

  • People whose cancer is located at the food pipe–stomach junction but classified as a different subtype (Siewert type I or II)
  • People who are unable or unwilling to take part in the study procedures
  • People who are unable or unwilling to have surgery
  • People who are pregnant at the time of the specialised imaging scan (called a PET/CT scan), due to radiation exposure from the experimental scan
  • People who are not able to make their own medical decisions
  • People with medical or mental health conditions that affect their ability to give informed consent
  • People who are unable to read or write and therefore cannot complete the questionnaires about quality of life and resource use
  • People who are unable to undergo a PET/CT scan, for example due to severe claustrophobia, exceeding the scanner's weight limit, or being unable to lie still and flat for around 30 minutes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +31 71 526 6029

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Leiden University Medical Center
Registry
ClinicalTrials.gov
Start date
3 July 2025
Est. completion
1 January 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change in treatment intent; Change in diagnostic work-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov